146 related articles for article (PubMed ID: 29436617)
1. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.
Qi ZH; Xu HX; Zhang SR; Xu JZ; Li S; Gao HL; Jin W; Wang WQ; Wu CT; Ni QX; Yu XJ; Liu L
Int J Oncol; 2018 Apr; 52(4):1105-1116. PubMed ID: 29436617
[TBL] [Abstract][Full Text] [Related]
2. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
[TBL] [Abstract][Full Text] [Related]
3. 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells.
Zhao J; O'Donnell VB; Balzar S; St Croix CM; Trudeau JB; Wenzel SE
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14246-51. PubMed ID: 21831839
[TBL] [Abstract][Full Text] [Related]
4. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
7. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway.
Zhang D; Wang L; Guo HL; Zhang ZW; Wang C; Chian RC; Zhang ZF
Int J Mol Med; 2020 Dec; 46(6):2078-2088. PubMed ID: 33125090
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human myoblast differentiation by PEBP4.
Garcia R; Grindlay J; Rath O; Fee F; Kolch W
EMBO Rep; 2009 Mar; 10(3):278-84. PubMed ID: 19197339
[TBL] [Abstract][Full Text] [Related]
10. GABRP Promotes the Metastasis of Pancreatic Cancer by Activation of the MEK/ERK Signaling Pathway.
Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
[TBL] [Abstract][Full Text] [Related]
11. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
[TBL] [Abstract][Full Text] [Related]
12. Pranlukast, a novel binding ligand of human Raf1 kinase inhibitory protein.
Sun T; Wu Z; Luo M; Lin D; Guo C
Biotechnol Lett; 2016 Aug; 38(8):1375-80. PubMed ID: 27146207
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
Anders M; Christian C; McMahon M; McCormick F; Korn WM
Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
15. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract][Full Text] [Related]
16. Human alphaA- and alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK and AKT signaling pathways.
Liu JP; Schlosser R; Ma WY; Dong Z; Feng H; Liu L; Huang XQ; Liu Y; Li DW
Exp Eye Res; 2004 Sep; 79(3):393-403. PubMed ID: 15336502
[TBL] [Abstract][Full Text] [Related]
17. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer.
Xin B; He X; Wang J; Cai J; Wei W; Zhang T; Shen X
Pancreatology; 2016; 16(6):1005-1014. PubMed ID: 27654574
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
20. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
